Skip to main content
. 2013 Jun 18;13:293. doi: 10.1186/1471-2407-13-293

Figure 2.

Figure 2

Kaplan-Meier curves for disease-free survival (DFS) and overall survival (OS) of nasopharyngeal carcinoma (NPC) patients withBAXmRNA-positive and -negative nasopharyngeal tumors.BAX mRNA expression status possesses a favorable prognostic value in NPC, as patients with BAX mRNA-positive nasopharyngeal tumors have significantly longer DFS (P = 0.001) (A) and OS (P < 0.001) (B), compared to NPC patients with BAX mRNA-negative tumors.